CeriBell, Financial Statements From 2010 to 2025
| CBLL Stock | 21.71 0.32 1.50% |
Check CeriBell, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CeriBell,'s main balance sheet or income statement drivers, such as , as well as many indicators such as . CeriBell, financial statements analysis is a perfect complement when working with CeriBell, Valuation or Volatility modules.
CeriBell, | Build AI portfolio with CeriBell, Stock |
CeriBell, Company Operating Margin Analysis
CeriBell,'s Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CeriBell, Operating Margin | (0.65) % |
Most of CeriBell,'s fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CeriBell, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CeriBell, has an Operating Margin of -0.6484%. This is 98.15% lower than that of the Health Care Equipment & Supplies sector and 98.35% lower than that of the Health Care industry. The operating margin for all United States stocks is 88.23% lower than that of the firm.
CeriBell, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CeriBell,'s current stock value. Our valuation model uses many indicators to compare CeriBell, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CeriBell, competition to find correlations between indicators driving CeriBell,'s intrinsic value. More Info.CeriBell, is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value CeriBell, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About CeriBell, Financial Statements
CeriBell, investors utilize fundamental indicators, such as revenue or net income, to predict how CeriBell, Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of CeriBell, Correlation against competitors. For more information on how to buy CeriBell, Stock please use our How to buy in CeriBell, Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell,. If investors know CeriBell, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CeriBell, is measured differently than its book value, which is the value of CeriBell, that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell,'s value that differs from its market value or its book value, called intrinsic value, which is CeriBell,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell,'s market value can be influenced by many factors that don't directly affect CeriBell,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.